概括
乳腺瘤中的孕激素受体表明对内分泌治疗的积极反应. 具有孕激素受体的瘤呈现出回归,表明它们作为预测标记物的价值.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 内分泌疗法是对激素敏感乳腺癌的基石治疗.
- 预测患者对内分泌治疗的反应仍然是一个临床挑战.
- 激素受体,包括雌激素受体 (ER) 和孕激素受体 (PR),是乳腺癌的关键生物标志物.
研究的目的:
- 研究孕激素受体 (PR) 作为人类乳腺瘤内分泌治疗反应的预测标记物的作用.
- 为了确定PR存在与内分泌治疗后瘤回归之间的相关性.
主要方法:
- 在人类乳腺瘤样本中分析孕激素受体表达.
- PR状态与雌激素受体 (ER) 状态的相关性.
- 基于PR表达的内分泌治疗瘤反应的临床评估.
主要成果:
- 在56%的瘤中检测到孕激素受体,这些瘤也表达了雌激素受体.
- 在缺乏雌激素受体的瘤中,孕激素受体始终缺席.
- 观察到一个显著的临床相关性:只有对孕激素受体阳性的乳腺瘤在内分泌治疗后表现出回归.
结论:
- 人类乳腺瘤中孕激素受体的存在是对内分泌治疗反应的敏感指标.
- PR状态,特别是与ER状态相结合,可以帮助预测治疗结果.
- PR阳性瘤代表了一个可能受益于内分泌干预的子组.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...